MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
DENTSPLY SIRONA EV - Enterprise Value 2011-2026 | XRAY
Annual EV - Enterprise Value DENTSPLY SIRONA
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.04 B | 10.6 B | 11.5 B | 15.5 B | 15.6 B | 15.4 B | 12.6 B | 17.5 B | 15.4 B | 10 B | 9.27 B | 9.07 B | 8.59 B | 8.14 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 17.5 B | 7.04 B | 11.9 B |
EV - Enterprise Value of other stocks in the Medical instruments industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
636 M | - | - | $ 810 M |  USA |
 |
Becton, Dickinson and Company
BDX
|
55.5 B | $ 184.86 | 1.31 % | $ 53.2 B | USA |
 |
Baxter International
BAX
|
21.6 B | $ 21.74 | 1.85 % | $ 11.2 B | USA |
 |
Luminex Corporation
LMNX
|
456 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
631 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
758 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
726 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
66.3 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
6.3 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
451 M | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
17.1 M | $ 11.29 | -8.21 % | $ 228 M | USA |
 |
ICU Medical
ICUI
|
3.36 B | $ 155.85 | 4.08 % | $ 3.84 B | USA |
 |
Alcon
ALC
|
7.12 B | $ 82.21 | -1.21 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
1.55 B | $ 32.79 | 1.27 % | $ 1.57 B | USA |
 |
electroCore
ECOR
|
-1.64 M | $ 6.16 | -0.16 % | $ 34 K | USA |
 |
Harvard Bioscience
HBIO
|
248 M | $ 0.58 | -0.56 % | $ 24.6 M | USA |
 |
LeMaitre Vascular
LMAT
|
2.26 B | $ 92.55 | 0.75 % | $ 2.08 B | USA |
 |
AngioDynamics
ANGO
|
396 M | $ 11.22 | 0.13 % | $ 458 M | USA |
 |
InfuSystem Holdings
INFU
|
197 M | $ 7.9 | - | $ 163 M | USA |
 |
The Cooper Companies
COO
|
20.4 B | $ 84.11 | 0.51 % | $ 16.7 B | USA |
 |
Haemonetics Corporation
HAE
|
2.76 B | $ 61.61 | 1.55 % | $ 3.1 B | USA |
 |
iRhythm Technologies
IRTC
|
5.71 B | $ 150.56 | -5.24 % | $ 4.82 B | USA |
 |
Isoray
ISR
|
13.3 M | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
4.69 B | $ 119.69 | 2.21 % | $ 5.8 B | USA |
 |
Repro Med Systems
KRMD
|
93.3 M | $ 4.72 | 0.64 % | $ 215 M | USA |
 |
OraSure Technologies
OSUR
|
60.6 M | $ 2.76 | -2.47 % | $ 205 M | USA |
 |
Masimo Corporation
MASI
|
10.4 B | $ 175.38 | 0.03 % | $ 9.35 B | USA |
 |
Intuitive Surgical
ISRG
|
170 B | $ 504.2 | 0.93 % | $ 180 B | USA |
 |
Merit Medical Systems
MMSI
|
6.6 B | $ 82.25 | 0.5 % | $ 4.79 B | USA |
 |
Microbot Medical
MBOT
|
13.1 M | $ 2.07 | -3.95 % | $ 21.1 M |  Israel |
 |
Nephros
NEPH
|
21.7 M | $ 4.14 | 6.43 % | $ 43 M | USA |
 |
NeuroMetrix
NURO
|
8.29 M | - | 5.05 % | $ 9.02 M | USA |
 |
Milestone Scientific
MLSS
|
70.1 M | $ 0.26 | -2.04 % | $ 20.7 M | USA |
 |
Envista Holdings Corporation
NVST
|
3.62 B | $ 29.16 | 1.53 % | $ 4.9 B | USA |
 |
Pro-Dex
PDEX
|
175 M | $ 39.55 | 1.41 % | $ 130 M | USA |
 |
Pulse Biosciences
PLSE
|
1.64 B | $ 21.98 | -12.38 % | $ 1.48 B | USA |
 |
Predictive Oncology
POAI
|
12.7 M | - | - | $ 31.1 M | USA |
 |
Stereotaxis
STXS
|
216 M | $ 2.08 | -0.24 % | $ 168 M | USA |
 |
Repligen Corporation
RGEN
|
126 M | $ 136.76 | -0.34 % | $ 7.62 M | USA |
 |
ResMed
RMD
|
36.5 B | $ 258.04 | 0.68 % | $ 37.7 B | USA |
 |
BioLife Solutions
BLFS
|
1.09 B | $ 23.17 | -0.26 % | $ 1.07 B | USA |
 |
STERIS plc
STE
|
27.5 B | $ 250.32 | -0.34 % | $ 24.7 B | USA |
 |
Retractable Technologies
RVP
|
90.3 M | $ 0.67 | -3.48 % | $ 20.1 M | USA |
 |
STAAR Surgical Company
STAA
|
800 M | $ 17.65 | -1.29 % | $ 867 M | USA |
 |
Teleflex Incorporated
TFX
|
8.74 B | $ 115.88 | 3.65 % | $ 5.43 B | USA |
 |
Utah Medical Products
UTMD
|
162 M | $ 67.96 | 2.09 % | $ 247 M | USA |
 |
West Pharmaceutical Services
WST
|
17.9 B | $ 241.54 | -0.94 % | $ 17.5 B | USA |